Assays of CFTR Function In Vitro, Ex Vivo and In Vivo

Anabela Santo Ramalho1, Mieke Boon1,2, Marijke Proesmans1,2

  • 1CF Research Lab, Woman and Child Unit, Department of Development and Regeneration, KU Leuven (Catholic University of Leuven), B-3000 Leuven, Belgium.

Insights

Accurate measurement of cystic fibrosis transmembrane conductance regulator (CFTR) protein function is crucial for diagnosis and monitoring CFTR-restoring therapies. This review details various in vitro, ex vivo, and in vivo bioassays used to quantify CFTR function, discussing their pros and cons.

Area of Science:

  • Biomedical Engineering
  • Molecular Biology
  • Genetics

Background:

  • Cystic fibrosis is a multi-organ genetic disorder caused by defective cystic fibrosis transmembrane conductance regulator (CFTR) protein function.
  • CFTR is a chloride channel essential for epithelial cell function.
  • Developing effective CFTR-restoring therapies necessitates reliable methods to assess CFTR function.

Purpose of the Study:

  • To review and compare available bioassays for quantitative CFTR function evaluation.
  • To discuss the indications, advantages, and disadvantages of each assay.
  • To correlate assay results with clinical outcomes.

Main Methods:

  • In vitro assays: direct/indirect ion flux measurements, fluorescence quenching, patch clamp, Ussing chamber, organoid swelling.
  • Ex vivo/in vivo assays: intestinal current measurement, nasal potential difference, sweat tests.
  • Evaluation of CFTR function across different biological contexts.

Main Results:

  • Various bioassays exist for CFTR function assessment, utilizing different biological systems and measurement techniques.
  • Each method offers unique advantages and disadvantages regarding accuracy, invasiveness, and applicability.
  • Correlation between bioassay results and clinical outcomes is essential for therapeutic assessment.

Conclusions:

  • A range of bioassays are available for quantitative CFTR function assessment.
  • Selection of the appropriate assay depends on the specific clinical or research question.
  • Continued development and validation of these assays are vital for advancing cystic fibrosis care.